PPARA and metabolic dysfunction-associated steatotic liver disease: In animal models PPAR-α deficiency showed a parallel trend with worsening hepatic steatosis, however, activation of the receptor by typical PPAR-α agonists (e.g. fibrates) did not show a significant effect on NAFLD, although serum TGs were reduced [153].